Here is this week’s Hot or Not.
Hot: AI in drug discovery
Google’s drug discovery spinout Isomorphic Labs just raised a $2.1B Series B round, with participation from Thrive Capital and Google Ventures.
The capital is earmarked for its drug design engine and global expansion, with existing pharma partnerships with J&J, Eli Lilly, and Novartis already in place.
AI could cut years off the discovery process and compress clinical trial times by up to 30%, accelerating delivery of new treatments and enabling more personalized medicine.
See all 225 AI-driven drug R&D companies in our market map.